中國奧園(03883.HK)擬11.6億元收購2.29億股京漢股份(000615.SZ)股份
格隆匯5月18日丨中國奧園(03883.HK)公佈,於2020年4月7日,賣方A京漢控股集團有限公司及賣方B建水泰融企業管理有限公司、田漢先生與買方奧園集團(廣東)有限公司(公司全資附屬公司)訂立框架協議,買方擬收購目標公司京漢實業投資集團股份有限公司(000615.SZ)約29.99%的股本,代價為現金人民幣11.6億元。
於2020年5月15日,賣方A、田先生及深圳奧園科星投資有限公司(買方附屬公司及公司間接全資附屬公司)訂立正式股份轉讓協議,據此,奧園科星已同意有條件地收購及賣方A已同意有條件地出售目標公司2.29億股股份,佔目標公司股本約29.30%,相等於已發行附帶投票權股份約29.99%,代價約人民幣11.6億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.